03.19.25 -- A Quest To Bring Gene Therapies To Common Diseases

Join Cell & Gene: The Podcast Host Erin Harris as she talks with Dr. Simrit Parmar, Founder of Cellenkos, about pioneering umbilical cord blood-derived Treg cell therapies for autoimmune and inflammatory diseases. Discover the advantages of cord blood-derived Tregs, Cellenkos’ CRANE technology, and key insights from their Phase 1b trial for CK0804. Plus, hear about the challenges of scaling off-the-shelf Treg therapies and what’s next for Cellenkos in 2025.

Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from oncology CROs.

Meet Marcelo, an infectious disease scientist, professor, pediatric patient advocate, and grieving father, as he shares his hopes for the future of pediatric clinical research.

Explore how tools streamline the development of cell-based therapies by optimizing processes, reducing costs, and accelerating manufacturing scalability. 

Characterizing impurities through advanced analytics is a critical step in ensuring biotherapeutic product quality. Learn more about the growing role of CDMOs in developing these products.

Discover an engaging and educational solution that transforms growth hormone deficiency treatment into a routine that helps children and parents manage daily therapy demands effectively.